Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Targeting of DNA Damage Response in Cancer. | Int J Mol Sci | 2022 | 35163621 | PubTator, text mining | PubMed |
| Challenges of CRISPR-Based Gene Editing in Primary T Cells. | Int J Mol Sci | 2022 | 35163611 | PubTator, text mining | PubMed |
| Usher Syndrome Belongs to the Genetic Diseases Associated with Radiosensitivity: Influence of the ATM Protein Kinase. | Int J Mol Sci | 2022 | 35163494 | PubTator, text mining | PubMed |
| Homologous Recombination-Enhancing Factors Identified by Comparative Transcriptomic Analyses of Pluripotent Stem Cell of Human and Common Marmoset. | Cells | 2022 | 35159172 | PubTator, text mining | PubMed |
| Metnase and EEPD1: DNA Repair Functions and Potential Targets in Cancer Therapy. | Front Oncol | 2022 | 35155245 | PubTator, text mining | PubMed |
| Physical ARTEMIS:DNA-PKcs interaction is necessary for V(D)J recombination. | Nucleic Acids Res | 2022 | 35150269 | PubTator, text mining | PubMed |
| Beta human papillomavirus 8 E6 allows colocalization of non-homologous end joining and homologous recombination repair factors. | PLoS Pathog | 2022 | 35148356 | PubTator, text mining | PubMed |
| Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair. | Cancer Manag Res | 2022 | 35115826 | PubTator, text mining | PubMed |
| Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours. | EMBO Mol Med | 2022 | 35107878 | PubTator, text mining | PubMed |
| Diversity upon diversity: linking DNA double-strand break repair to blood cancer health disparities. | Trends Cancer | 2022 | 35094960 | PubTator, text mining | PubMed |
| DNA Repair Capacity for Personalizing Risk and Treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs). | DNA Repair (Amst) | 2022 | 35085879 | PubTator, text mining | PubMed |
| USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. | Nat Commun | 2022 | 35079021 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| CRISPR-based genome editing through the lens of DNA repair. | Mol Cell | 2022 | 35063100 | PubTator, text mining | PubMed |
| XRCC4 and MRE11 Roles and Transcriptional Response to Repair of TALEN-Induced Double-Strand DNA Breaks. | Int J Mol Sci | 2022 | 35054780 | PubTator, text mining | PubMed |
| WASH interacts with Ku to regulate DNA double-stranded break repair. | iScience | 2022 | 35036867 | PubTator, text mining | PubMed |
| 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis. | Nat Cell Biol | 2022 | 35027730 | PubTator, text mining | PubMed |
| Species variations in XRCC1 recruitment strategies for FHA domain-containing proteins. | DNA Repair (Amst) | 2022 | 35026705 | PubTator, text mining | PubMed |
| Optimization of Long-Term Human iPSC-Derived Spinal Motor Neuron Culture Using a Dendritic Polyglycerol Amine-Based Substrate. | ASN Neuro | 2022 | 35023784 | PubTator, text mining | PubMed |
| Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy. | Clin Cancer Res | 2022 | 35022323 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=32